rs11130254

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001243925.2(MAPKAPK3):​c.*721A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0801 in 152,320 control chromosomes in the GnomAD database, including 682 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.080 ( 682 hom., cov: 34)
Exomes 𝑓: 0.059 ( 0 hom. )

Consequence

MAPKAPK3
NM_001243925.2 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.912

Publications

20 publications found
Variant links:
Genes affected
MAPKAPK3 (HGNC:6888): (MAPK activated protein kinase 3) This gene encodes a member of the Ser/Thr protein kinase family. This kinase functions as a mitogen-activated protein kinase (MAP kinase)- activated protein kinase. MAP kinases are also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This kinase was shown to be activated by growth inducers and stress stimulation of cells. In vitro studies demonstrated that ERK, p38 MAP kinase and Jun N-terminal kinase were all able to phosphorylate and activate this kinase, which suggested the role of this kinase as an integrative element of signaling in both mitogen and stress responses. This kinase was reported to interact with, phosphorylate and repress the activity of E47, which is a basic helix-loop-helix transcription factor known to be involved in the regulation of tissue-specific gene expression and cell differentiation. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2011]
MAPKAPK3 Gene-Disease associations (from GenCC):
  • patterned macular dystrophy 3
    Inheritance: AD, Unknown Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPKAPK3NM_001243925.2 linkc.*721A>C 3_prime_UTR_variant Exon 11 of 11 ENST00000621469.5 NP_001230854.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPKAPK3ENST00000621469.5 linkc.*721A>C 3_prime_UTR_variant Exon 11 of 11 1 NM_001243925.2 ENSP00000478922.1
MAPKAPK3ENST00000357955.6 linkc.*721A>C 3_prime_UTR_variant Exon 11 of 11 1 ENSP00000350639.2
MAPKAPK3ENST00000446044.5 linkc.*721A>C 3_prime_UTR_variant Exon 13 of 13 1 ENSP00000396467.1
MAPKAPK3ENST00000451680.1 linkc.*721A>C downstream_gene_variant 2 ENSP00000394894.1

Frequencies

GnomAD3 genomes
AF:
0.0802
AC:
12200
AN:
152168
Hom.:
682
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0232
Gnomad AMI
AF:
0.137
Gnomad AMR
AF:
0.0707
Gnomad ASJ
AF:
0.0386
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0145
Gnomad FIN
AF:
0.133
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.121
Gnomad OTH
AF:
0.0747
GnomAD4 exome
AF:
0.0588
AC:
2
AN:
34
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
24
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.0500
AC:
1
AN:
20
Other (OTH)
AF:
0.250
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0801
AC:
12201
AN:
152286
Hom.:
682
Cov.:
34
AF XY:
0.0797
AC XY:
5934
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.0231
AC:
960
AN:
41582
American (AMR)
AF:
0.0707
AC:
1082
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0386
AC:
134
AN:
3468
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5182
South Asian (SAS)
AF:
0.0147
AC:
71
AN:
4820
European-Finnish (FIN)
AF:
0.133
AC:
1408
AN:
10606
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.121
AC:
8243
AN:
68012
Other (OTH)
AF:
0.0739
AC:
156
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
600
1200
1800
2400
3000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
1574
Bravo
AF:
0.0728
Asia WGS
AF:
0.0120
AC:
43
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.4
DANN
Benign
0.51
PhyloP100
0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11130254; hg19: chr3-50686198; API